(Q35881311)

10 August 2017

title

Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders (English)

1 reference

10 August 2017

1

Dennis A Revicki

1 reference

10 August 2017

5

Nicholas J Talley

1 reference

10 August 2017

Anne M Rentz

2

1 reference

10 August 2017

Jan Tack

3

1 reference

10 August 2017

Vincenzo Stanghellini

4

1 reference

10 August 2017

Peter Kahrilas

6

1 reference

10 August 2017

Christine De La Loge

7

1 reference

10 August 2017

Elyse Trudeau

8

1 reference

10 August 2017

Dominique Dubois

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Clinical Gastroenterology and Hepatology

10 August 2017

published in

1 reference

10 August 2017

volume

2

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

769-777

1 reference

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Methods to explain the clinical significance of health status measures

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Recommendations on health-related quality of life research to support labeling and promotional claims in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Assessing health status and quality-of-life instruments: attributes and review criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Functional gastroduodenal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Effect sizes for interpreting changes in health status.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Defining clinically meaningful change in health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

Interpretation of quality of life changes

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900348-9

7 January 2021

10.1016/S1542-3565(04)00348-9

Identifiers

DOI

1 reference

10 August 2017

1 reference